Results 111 to 120 of about 1,862,216 (244)

Mystery and misery of locally‐delivered drug therapy in periodontics. Historical concepts and current state

open access: yesPeriodontology 2000, EarlyView.
Abstract The primary objective is to critically analyze approaches to local therapy for periodontal disease, particularly in light of its well‐established systemic implications. We specifically address common misconceptions and overestimations regarding the potential of local treatments in contrast to their actual clinical effectiveness.
Andrea Mombelli, Alkisti Zekeridou
wiley   +1 more source

Integrating DCE‐MRI‐Based Dural Drainage Function Indicators into Machine Learning Models for Improved Intracranial Tumor Prognosis

open access: yesMedComm, Volume 7, Issue 10, October 2026.
We integrated DCE‐MRI‐based dural drainage function indicators (DDFIs) that reflect meningeal lymphatic vessels (mLVs) function into XGBoost models to predict the prognosis of intracranial malignant tumors. In a 2.5‐year follow‐up cohort of 100 patients, DDFIs remarkably improved the model's predictive performance, with a more significant enhancement ...
Lusen Ran   +14 more
wiley   +1 more source

Right coronary artery thrombosis within drug eluting stents more than 10 years after deployment: Two cases of very, very late stent thrombosis

open access: yesHeart Vessels and Transplantation, 2017
We present two rare cases of very late stent thrombosis occurring beyond ten years post initial drug eluting stent deployment.
Sam Lovibond, Michael Leung
doaj   +1 more source

Graphene Oxide Formation Mechanism and Organosulfates Interlayer Bridging

open access: yesChemistrySelect, Volume 11, Issue 37, 6 October 2026.
Graphene oxide formation was investigated using a modified Hummers method, revealing that oxidation is completed within 2 h, with no advantages from longer reaction times. Sulfur functionalities are introduced early and persist throughout the process. At extended times, interlayer sulfate bridges form, limiting exfoliation.
Lícia Maria D'Arezzo Maestrelli   +1 more
wiley   +1 more source

Coronary collateral function long after drug-eluting stent implantation [PDF]

open access: yes, 2007
OBJECTIVES: This study was designed to compare coronary collateral function in patients after bare-metal stent (BMS) or drug-eluting stent (DES) implantation.
Windecker, Stephan   +13 more
core   +1 more source

Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turkey

open access: yesInternational Journal of Medical Sciences, 2011
Background: Our purpose was to investigate the clinical outcomes of Zotarolimus- and Paclitaxel-eluting stents in Turkish patients with coronary artery disease (CAD).
Davran Çiçek, Hasan Pekdemir, Cevahir Haberal, Nihat Kalay, Süleyman Binici, Hakan Altay, Haldun Müderrisoğlu
doaj  

Interfacing exogenous stents with human coronary artery by self-assembled coating: designs, functionalities and applications

open access: yesNPG Asia Materials
Drug-eluting stents are a commonly used treatment for coronary artery disease. However, the coatings used in drug-eluting stents have some limitations such as poor biocompatibility and drug loading capacity.
Feng Zhao   +14 more
doaj   +1 more source

Drug eluting balloons in femoro-popliteal artery disease

open access: yesThe Egyptian Heart Journal, 2014
Treatment of femoropopliteal artery disease by percutaneous transluminal angioplasty (PTA) is limited by high rates of restenosis (40% to 60%) 6 to 12 months after procedure.
Ahmed S. Gaweesh
doaj   +1 more source

Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice

open access: yesAging Cell, Volume 25, Issue 10, October 2026.
Rapamycin exerts multifaceted immunomodulatory effects in age‐induced atherosclerosis, with pronounced inhibitory effects on adaptive immunity. Rapamycin reduced plaque inflammation and macrophage content, diminished pro‐inflammatory T cell responses, lowered age‐associated B cell frequencies, and attenuated senescence‐associated immune signatures ...
Jill de Mol   +9 more
wiley   +1 more source

Drug Eluting Stents for Vulnerable Plague

open access: yesCurrent Pharmaceutical Design, 2010
A vulnerable plaque is an atheromatic plaque with specific morphological characteristics, mainly presented as an unstable collection of white blood cells and lipids in the wall of an artery. It is of great importance to adequately recognize and treat this entity before its rupture, before the initiation of an acute coronary syndrome.
Toutouzas, K.   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy